Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.

Mirella Georgouli | Cecilia Herraiz | Eva Crosas-Molist | Bruce Fanshawe | Oscar Maiques | Anna Perdrix | Pahini Pandya | Irene Rodriguez-Hernandez | Kristina M Ilieva | Gaia Cantelli | Panagiotis Karagiannis | Silvia Mele | Hoyin Lam | Debra H Josephs | Xavier Matias-Guiu | Rosa M Marti | Frank O Nestle | Jose L Orgaz | Ilaria Malanchi | Gilbert O Fruhwirth | Sophia N Karagiannis | Victoria Sanz-Moreno
Cell | 2019

ROCK-Myosin II drives fast rounded-amoeboid migration in cancer cells during metastatic dissemination. Analysis of human melanoma biopsies revealed that amoeboid melanoma cells with high Myosin II activity are predominant in the invasive fronts of primary tumors in proximity to CD206+CD163+ tumor-associated macrophages and vessels. Proteomic analysis shows that ROCK-Myosin II activity in amoeboid cancer cells controls an immunomodulatory secretome, enabling the recruitment of monocytes and their differentiation into tumor-promoting macrophages. Both amoeboid cancer cells and their associated macrophages support an abnormal vasculature, which ultimately facilitates tumor progression. Mechanistically, amoeboid cancer cells perpetuate their behavior via ROCK-Myosin II-driven IL-1α secretion and NF-κB activation. Using an array of tumor models, we show that high Myosin II activity in tumor cells reprograms the innate immune microenvironment to support tumor growth. We describe an unexpected role for Myosin II dynamics in cancer cells controlling myeloid function via secreted factors.

Pubmed ID: 30712866

Research resources used in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: Cancer Research UK, United Kingdom
    Id: 12065
  • Agency: Cancer Research UK, United Kingdom
    Id: C48390/A21153
  • Agency: Medical Research Council, United Kingdom
    Id: FC001112
  • Agency: Wellcome Trust, United Kingdom
    Id: FC001112
  • Agency: Worldwide Cancer Research, United Kingdom
    Id: 16-1135
  • Agency: Cancer Research UK, United Kingdom
    Id: C10355/A15587
  • Agency: Cancer Research UK, United Kingdom
    Id: 24478
  • Agency: Department of Health, United Kingdom
    Id: IS-BRC-1215-20006
  • Agency: Cancer Research UK, United Kingdom
    Id: C33043/A24478
  • Agency: Medical Research Council, United Kingdom
    Id: MR/L023091/1
  • Agency: Cancer Research UK, United Kingdom
    Id: FC001112
  • Agency: Cancer Research UK, United Kingdom
    Id: C30122/A15774
  • Agency: Cancer Research UK, United Kingdom
    Id: C30122/A11527

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

ClinicalTrials.gov (tool)

RRID:SCR_002309

Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.

View all literature mentions

GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

RayBiotech (tool)

RRID:SCR_005517

An Antibody supplier

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

MetaCore (tool)

RRID:SCR_008125

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on March 17, 2022. An integrated software suite for functional analysis of experimental data. The scope of data types includes microarray and SAGE gene expression, SNPs and CGH arrays, proteomics, metabolomics, pathway analysis, Y2H and other custom interactions. MetaCore is based on a proprietary manually curated database of human protein-protein, protein-DNA and protein compound interactions, metabolic and signaling pathways and the effects of bioactive molecules in gene expression.

View all literature mentions

FlowJo (tool)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

Dako (tool)

RRID:SCR_013530

An Antibody supplier; Dako was purchased by Agilent in 2012 and several years later the websites began to reflect the Dako products as part of the Agilent catalog.

View all literature mentions

Microsoft Excel (tool)

RRID:SCR_016137

Software application with data analysis tools and spreadsheet templates to track and visualize data. It is used to manage and process data.

View all literature mentions

BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

B16-F10 (tool)

RRID:CVCL_0159

Cell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

HUVEC-C (tool)

RRID:CVCL_2959

Cell line HUVEC-C is a Finite cell line with a species of origin Homo sapiens

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

HUVEC-C (tool)

RRID:CVCL_2959

Cell line HUVEC-C is a Finite cell line with a species of origin Homo sapiens

View all literature mentions

U-937 (tool)

RRID:CVCL_0007

Cell line U-937 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

THP-1 (tool)

RRID:CVCL_0006

Cell line THP-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U-937 (tool)

RRID:CVCL_0007

Cell line U-937 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Mouse IgG1 Isotype Control (Clone 11711) (antibody)

RRID:AB_357344

This unknown targets Mouse IgG1 Isotype Control (Clone 11711)

View all literature mentions

Myosin Light Chain 2 Antibody (antibody)

RRID:AB_330278

This polyclonal targets Myosin Light Chain 2

View all literature mentions

ROCK-I (antibody)

RRID:AB_398448

This monoclonal targets ROCK-I

View all literature mentions

Phospho-Myosin Light Chain 2 (Thr18/Ser19) Antibody (antibody)

RRID:AB_2147464

This polyclonal targets Phospho-Myosin Light Chain 2 (Thr18/Ser19)

View all literature mentions

Cadherin-5 (antibody)

RRID:AB_2276073

This monoclonal targets Cadherin-5

View all literature mentions

F4/80 antibody (antibody)

RRID:AB_10675322

This polyclonal targets F4/80 antibody

View all literature mentions

Human CXCL8/IL-8 MAb (Clone 6217) (antibody)

RRID:AB_2249110

This monoclonal targets Human CXCL8/IL-8 MAb (Clone 6217)

View all literature mentions

PE/Cyanine7 anti-human CD86 (antibody)

RRID:AB_2275754

This monoclonal targets CD86

View all literature mentions

Cofilin (D59) Antibody (antibody)

RRID:AB_2080595

This unknown targets Cfl1

View all literature mentions

Anti-Mannose Receptor antibody (antibody)

RRID:AB_1523910

This polyclonal targets Mannose Receptor

View all literature mentions

Phospho-I B (Ser32) (14D4) Rabbit mAb (antibody)

RRID:AB_561111

This monoclonal targets Phospho-I B (Ser32)

View all literature mentions

Anti-CD31 antibody (antibody)

RRID:AB_726362

This polyclonal targets CD31

View all literature mentions

Phospho-Myosin Light Chain 2 (Ser19) Antibody (antibody)

RRID:AB_330248

This polyclonal targets Phospho-Myosin Light Chain 2 (Ser19)

View all literature mentions

PE anti-human CD206 (MMR) (antibody)

RRID:AB_571910

This monoclonal targets CD206

View all literature mentions